
Quest Diagnostics Incorporated DGX
$ 198.02
0.17%
Annual report 2025
added 02-26-2026
Quest Diagnostics Incorporated Total Inventories 2011-2026 | DGX
Annual Total Inventories Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 189 M | 188 M | 190 M | 192 M | 208 M | 223 M | 123 M | 99 M | 95 M | 82 M | 84 M | 110 M | 91 M | 93 M | 89.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 223 M | 82 M | 137 M |
Quarterly Total Inventories Quest Diagnostics Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 186 M | 187 M | 189 M | 184 M | 182 M | 181 M | 184 M | 184 M | 190 M | 192 M | 183 M | - | 197 M | 208 M | 205 M | 199 M | 223 M | 223 M | 223 M | 223 M | 223 M | 123 M | 123 M | 123 M | 123 M | 99 M | 99 M | 99 M | 99 M | 95 M | 95 M | 95 M | 95 M | 82 M | 82 M | 82 M | 82 M | 84 M | 84 M | 84 M | 84 M | 110 M | 110 M | 110 M | 110 M | 91 M | 91 M | 91 M | 91 M | 93 M | 93 M | 93 M | 93 M | 89.1 M | 89.1 M | 89.1 M | 89.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 223 M | 82 M | 133 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
830 M | $ 115.48 | 0.82 % | $ 35.1 B | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 16.2 | -0.61 % | $ 175 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
992 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 24.84 | -0.84 % | $ 690 M | ||
|
DarioHealth Corp.
DRIO
|
4.32 M | $ 8.4 | 3.7 % | $ 33.5 M | ||
|
BioNano Genomics
BNGO
|
7.83 M | $ 1.2 | 0.84 % | $ 6.53 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 173.89 | -0.58 % | $ 8.62 B | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
DexCom
DXCM
|
629 M | $ 62.22 | -0.24 % | $ 24.3 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.17 | -0.91 % | $ 4.98 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Guardant Health
GH
|
85.9 M | $ 93.83 | 2.94 % | $ 11.8 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 76.1 | 0.53 % | $ 5.14 B | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 1.96 | 5.82 % | $ 8.67 M | ||
|
Mettler-Toledo International
MTD
|
387 M | $ 1 259.94 | -1.11 % | $ 26 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 114.19 | 2.49 % | $ 9.42 B | ||
|
IDEXX Laboratories
IDXX
|
378 M | $ 569.55 | 0.87 % | $ 45.8 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.41 | 0.21 % | $ 2.04 B | ||
|
Illumina
ILMN
|
547 M | $ 127.38 | 0.59 % | $ 20.3 B | ||
|
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.34 | -0.74 % | $ 402 M | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 273.72 | 0.36 % | $ 22.8 B | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 4.75 | 3.49 % | $ 440 M | ||
|
Sotera Health Company
SHC
|
54.4 M | $ 14.96 | 0.61 % | $ 4.25 B | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.0 | 3.23 % | $ 1.02 B |